Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation Into the Role of Gastroesophageal Reflux in Pulmonary Fibrosis in Scleroderma

NCT02136394 is registered in ClinicalTrials.gov with Royal Brompton & Harefield NHS Foundation Trust as lead sponsor.

NCT NCT02136394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02136394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation Into the Role of Gastroesophageal Reflux in Pulmonary Fibrosis in Scleroderma
Lead sponsor
Royal Brompton & Harefield NHS Foundation Trust
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2014
Completion date
April 30, 2017
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux, interstitial lung disease, systemic sclerosis